Cargando…
Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3) N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II)
In the title compound, [ZnBr(2)(C(22)H(19)ClN(4)O)], the Zn(II) atom adopts a distorted square-pyramidal coordination geometry, formed by two bromido ligands and three N atoms of the bis(pyridin-2-ylmethyl)amine moiety in the pentadentate ligand containing quinolinol. The Zn(II) atom is located w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900503/ https://www.ncbi.nlm.nih.gov/pubmed/35371540 http://dx.doi.org/10.1107/S2056989022001530 |
_version_ | 1784664128466452480 |
---|---|
author | Kubono, Koji Kashiwagi, Yukiyasu Tani, Keita Yokoi, Kunihiko |
author_facet | Kubono, Koji Kashiwagi, Yukiyasu Tani, Keita Yokoi, Kunihiko |
author_sort | Kubono, Koji |
collection | PubMed |
description | In the title compound, [ZnBr(2)(C(22)H(19)ClN(4)O)], the Zn(II) atom adopts a distorted square-pyramidal coordination geometry, formed by two bromido ligands and three N atoms of the bis(pyridin-2-ylmethyl)amine moiety in the pentadentate ligand containing quinolinol. The Zn(II) atom is located well above the mean basal plane of the square-based pyramid. The apical position is occupied by a Br atom. The O and N atoms of the quinolinol moiety in the ligand are not coordinated to the Zn(II) atom. An intramolecular O—H⋯N hydrogen bond, generating an S(5) ring motif, stabilizes the molecular structure. In the crystal, the molecules are linked by intermolecular C—H⋯Br hydrogen bonds, generating ribbon structures containing alternating R (2) (2)(22) and R (2) (2)(14) rings. These ribbons are linked through an intermolecular C—H⋯Br hydrogen bond, forming a two-dimensional network sheet. |
format | Online Article Text |
id | pubmed-8900503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-89005032022-03-31 Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3) N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) Kubono, Koji Kashiwagi, Yukiyasu Tani, Keita Yokoi, Kunihiko Acta Crystallogr E Crystallogr Commun Research Communications In the title compound, [ZnBr(2)(C(22)H(19)ClN(4)O)], the Zn(II) atom adopts a distorted square-pyramidal coordination geometry, formed by two bromido ligands and three N atoms of the bis(pyridin-2-ylmethyl)amine moiety in the pentadentate ligand containing quinolinol. The Zn(II) atom is located well above the mean basal plane of the square-based pyramid. The apical position is occupied by a Br atom. The O and N atoms of the quinolinol moiety in the ligand are not coordinated to the Zn(II) atom. An intramolecular O—H⋯N hydrogen bond, generating an S(5) ring motif, stabilizes the molecular structure. In the crystal, the molecules are linked by intermolecular C—H⋯Br hydrogen bonds, generating ribbon structures containing alternating R (2) (2)(22) and R (2) (2)(14) rings. These ribbons are linked through an intermolecular C—H⋯Br hydrogen bond, forming a two-dimensional network sheet. International Union of Crystallography 2022-02-15 /pmc/articles/PMC8900503/ /pubmed/35371540 http://dx.doi.org/10.1107/S2056989022001530 Text en © Kubono et al. 2022 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Research Communications Kubono, Koji Kashiwagi, Yukiyasu Tani, Keita Yokoi, Kunihiko Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3) N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title | Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title_full | Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title_fullStr | Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title_full_unstemmed | Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title_short | Crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
N,N′,N′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(II) |
title_sort | crystal structure of (7-{[bis(pyridin-2-ylmethyl)amino-κ(3)
n,n′,n′′]methyl}-5-chloroquinolin-8-ol)dibromidozinc(ii) |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900503/ https://www.ncbi.nlm.nih.gov/pubmed/35371540 http://dx.doi.org/10.1107/S2056989022001530 |
work_keys_str_mv | AT kubonokoji crystalstructureof7bispyridin2ylmethylaminok3nnnmethyl5chloroquinolin8oldibromidozincii AT kashiwagiyukiyasu crystalstructureof7bispyridin2ylmethylaminok3nnnmethyl5chloroquinolin8oldibromidozincii AT tanikeita crystalstructureof7bispyridin2ylmethylaminok3nnnmethyl5chloroquinolin8oldibromidozincii AT yokoikunihiko crystalstructureof7bispyridin2ylmethylaminok3nnnmethyl5chloroquinolin8oldibromidozincii |